296 related articles for article (PubMed ID: 28146149)
1. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.
Ren X; Yang X; Cheng B; Chen X; Zhang T; He Q; Li B; Li Y; Tang X; Wen X; Zhong Q; Kang T; Zeng M; Liu N; Ma J
Nat Commun; 2017 Feb; 8():14053. PubMed ID: 28146149
[TBL] [Abstract][Full Text] [Related]
2. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
3. TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma.
Ren XY; Wen X; Li YQ; Zhang J; He QM; Yang XJ; Tang XR; Wang YQ; Zhang PP; Chen XZ; Cheng B; Ma J; Liu N
J Exp Clin Cancer Res; 2018 Sep; 37(1):227. PubMed ID: 30217224
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.
Li HP; Peng CC; Chung IC; Huang MY; Huang ST; Chen CC; Chang KP; Hsu CL; Chang YS
Oncotarget; 2013 Nov; 4(11):2154-65. PubMed ID: 24243817
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
[TBL] [Abstract][Full Text] [Related]
7. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.
Wang L; Sang Y; Tang J; Zhang RH; Luo D; Chen M; Deng WG; Kang T
J Pathol; 2015 Dec; 237(4):411-22. PubMed ID: 26147638
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
[TBL] [Abstract][Full Text] [Related]
10. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.
Kwong J; Chow LS; Wong AY; Hung WK; Chung GT; To KF; Chan FL; Daigo Y; Nakamura Y; Huang DP; Lo KW
Genes Chromosomes Cancer; 2007 Feb; 46(2):171-80. PubMed ID: 17099870
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
[TBL] [Abstract][Full Text] [Related]
14. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
[TBL] [Abstract][Full Text] [Related]
15. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
[TBL] [Abstract][Full Text] [Related]
17. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of
Zhang J; Li YQ; Guo R; Wang YQ; Zhang PP; Tang XR; Wen X; Hong XH; Lei Y; He QM; Yang XJ; Sun Y; Ma J; Liu N
Cancer Res; 2019 Feb; 79(4):747-759. PubMed ID: 30573520
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
20. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
